HCPCS code J7308: Aminolevulinic acid, per 354 mg form2026 Medicare rate & RVUs in California

CMS doesn’t publish an office rate for J7308 in California.

Medicare allowed amount for participating (non-QP) physicians, before deductible, coinsurance and claim adjustments. Not a patient’s bill or a hospital charge.

What J7308 covers

J7308 represents a topical 20% aminolevulinic acid hydrochloride preparation used to sensitize actinic keratoses for photodynamic treatment, commonly on the face or scalp. In dermatology practices, a clinician applies the drug to the lesions and then treats the area with external light; the medication and light procedure are distinct reported services.

A single unit corresponds to one single-use form containing 354 mg. CMS excludes J7308 from the physician fee schedule under status E. When Medicare covers it, payment is under another method: it is a Part B drug generally priced through CMS's quarterly ASP drug pricing files. The Medicare contractor determines coverage.

This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.

Where J7308 pays more and less in California

The same RVUs, adjusted for each area’s costs. Open a locality for its calculation, history and nearby areas.

29 of 29 payment localities

How the J7308 rate is calculated

Each of J7308’s three RVUs is multiplied by a geographic index (GPCI) for the payment locality, added up, and multiplied by the conversion factor. Drag the indexes or enter a ZIP to see what moves the rate.

Payment rules and modifiers for J7308

J7308 has no global surgery period, no multiple-procedure, bilateral or assistant-at-surgery adjustment, and no professional/technical split. What changes the payment is where the service happens: the place of service on the claim decides whether Medicare pays the office or the facility rate.

J7308 compared with similar codes

How to choose

96567Photodynamic therapyIncident-to treatment

J7308 identifies the topical photosensitizing drug. CPT 96567 describes the external-light photodynamic therapy service.

17000Premalignant lesion destructionFirst lesion

J7308 identifies the topical drug used with light therapy. CPT 17000 describes destructive treatment of the first premalignant skin lesion.

17004Premalignant lesion destruction15 or more lesions

J7308 identifies the drug used in light-based treatment. CPT 17004 describes destructive treatment when 15 or more premalignant skin lesions are treated.

Codes related to J7308

Related codes aren’t interchangeable: bill the code that matches the service performed.

Where these rates come from

FeeBase calculates base physician payments from CMS work, practice-expense and malpractice RVUs, adjusted by each locality’s geographic indexes and the conversion factor. Services without a published rate are labeled, never given a made-up amount. Amounts are Medicare allowed amounts before claim adjustments: not a patient’s bill or a commercial rate.

CMS RVU26D · effective Oct 1, 2026 through the day before Jan 1, 2027

Open CMS sourceHow we calculate rates